Palliative care pharmacotherapy literature summaries and analyses.
Timely and important studies are reviewed and commentaries provided by leading palliative care clinicians. Symptoms, interventions, and treatment-related adverse events addressed in this issue are computerized symptom management; anticholinergic agents in lung disease; neuropathic pain and morphine effectiveness; morphine dosing; inflammatory cytokines and pain; oral ghrelin-mimetics and sarcopenia; and opioid-induced bowel dysfunction.
Abernethy
Amy P
AP
Duke University Medical Center, Box 3436, Durham, NC 27710, USA. amy.abernethy@duke.edu
D000375:Aging; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D003248:Constipation / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D054439:Ghrelin / Q000502:physiology; D006801:Humans; D009020:Morphine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009133:Muscular Atrophy / Q000188:drug therapy / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy* / Q000517:prevention & control; D010166:Palliative Care / Q000379:methods*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic
D000701:Analgesics, Opioid; D054439:Ghrelin; D009020:Morphine